Skip to main content
Publications
Taylor PC, Betteridge N, Brown TM Whalley D Olayinka-Amao O Treatment mode preferences in rheumatoid arthritis: moving toward shared decision-making 10.2147/PPA.S220714
Walley D Twiss J Doward L Patient-reported symptoms and impact in nonalcoholic steatohepatitis: an evaluation of the NASH-CHECK, a novel PROM in NASH 10.1016/S0168-8278(20)33053-1
Breckons M, Doward L Twiss J Evaluating the patient-perceived impact of non-alcoholic steatohepatitis with compensated cirrhosis 10.1016/S0168-8278(20)33053-1
Lansdall CJ, Butler LM, Kerchner G, McDougall F, Delmar P, Pross N, Qin S McLeod L Anchor- and distribution-based methods to establish clinically meaningful score changes on the Clinical Dementia Rating Scale – Sum of Boxes in patients with prodromal Alzheimer's Disease
Twiss J Whalley D Doward L Psychometric evaluation of NASH-CHECK, a patient-reported outcome measure for Nonalcoholic Steatohepatitis
Simpson EL, de Bruin-Weller M, Eckert L, Whalley D Nelson L Qin S Responder threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in adolescents with atopic dermatitis 10.1007/s13555-019-00333-2
Lansdall CJ, Butler LM, Kerchner G, McDougall F, Delmar P, Pross N, Qin S, McLeod L Estimates of clinically meaningful change on the CDR-SB
Simpson E, Eckert L, Gadkari A, Mallya UG, Yang M, Nelson L Brown M Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis 10.1186/s12895-019-0095-3
Doward L Twiss J International adaptation and linguistic validation of NASH-CHECK, a novel patient-reported outcome measure for patients with Nonalcoholic Steatohepatitis
Yosipovitch G, Reaney M, Mastey V, Eckert L, Abbe A, Nelson L Clark M Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis 10.1111/bjd.17744
Hanna MG, Badrising UA, Benveniste O, Lloyd TE, Needham M, Chinoy H, Aoki M, Machado PM, Liang C, Reardon KA, de Visser M, Ascherman DP, Barohn RJ, Dimachkie MM, Miller JAL, Kissel JT, Joyce NC, Van den Bergh P, Baets J, De Bleecker JL, Karam C, David WS, Mirabella M, Nations SP, Jung HH, Pegoraro E, Maggi L, Rodolico C, Filosto M, Shaibani AL, Sivakumar K, Goyal NA, Mori-Yoshimura M, Yamashita S, Suzuki N, Katsuno M, Murata K, Nodera H, Nishino I, Romano C Williams VSL Safety and efficacy of intravenous bimagrumab in inclusion body myositis: a phase 2b, randomised, double-blind, placebo-controlled study (RESILIENT)
